-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q2 2024.
- Vir Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $22.2M, a 27.6% decline year-over-year.
- Vir Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $101M, a 4.39% decline year-over-year.
- Vir Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $111M, a 9.05% increase from 2022.
- Vir Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $102M, a 21.8% increase from 2021.
- Vir Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $83.8M, a 204% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)